Federal Court Blocks Mailing of Abortion Pill, Impacting Nationwide Access
A recent ruling by the 5th U.S. Circuit Court of Appeals has blocked the mailing of the abortion pill mifepristone, a decision that could significantly alter abortion access across the United States. The court's decision mandates that mifepristone, which was previously available via mail, must now be distributed in person at clinics. This ruling comes as a major victory for abortion opponents who argue that mail-order access undermines state bans on abortion. The decision has prompted Danco Laboratories, a manufacturer of mifepristone, to appeal to the Supreme Court to block the appellate court's ruling while further appeals are pending. The ruling affects all states, including those without abortion restrictions, and has sparked concerns about access for patients in remote areas. 
